Dealings involving an Intentional Release (DIR) of GMOs into the environment are dealings with GMOs which can take place outside of containment facilities.
Licence number | Project title | Organisation | Category | Release | Issue date | Licence status |
---|---|---|---|---|---|---|
Limited and controlled release of sorghum genetically modified for asexual seed formation |
The University of Queensland |
Agricultural | Limited and controlled | Current | ||
Limited and controlled release of canola and Indian mustard genetically modified for altered oil content and herbicide tolerance |
Nuseed Pty Ltd |
Agricultural | Limited and controlled | Current | ||
Limited and controlled release of wheat and barley genetically modified for yield enhancement and improved abiotic stress tolerance |
The University of Adelaide |
Agricultural | Limited and controlled | Current | ||
Clinical trial with a genetically modified Bordetella pertussis for the prevention of whooping cough |
PPD Australia Pty Ltd |
Medical | Limited and controlled | Current | ||
Clinical trial with a genetically modified human adenovirus COVID-19 vaccine |
Avance Clinical Pty Ltd |
Medical | Limited and controlled | Current | ||
Clinical trial with genetically modified E.coli to reduce antibiotic resistance |
The Westmead Institute for Medical Research |
Medical | Limited and controlled | Current | ||
Commercial supply of a genetically modified COVID-19 vaccine |
Janssen-Cilag Pty Ltd |
Medical | Commercial | Current | ||
Clinical trial of a genetically modified Herpes virus for the treatment of cystic fibrosis |
Novotech (Australia) Pty Limited |
Medical | Limited and controlled | Current | ||
Commercial supply of a genetically modified COVID-19 vaccine |
AstraZeneca Pty Ltd |
Medical | Commercial | Current | ||
Clinical trial with a genetically modified Vaccinia virus based treatment for solid cancerous tumours |
Novotech (Australia) Pty Limited |
Medical | Limited and controlled | Current | ||
Commercial release of canola genetically modified for herbicide tolerance and a hybrid breeding system (MS11× RF3 and MS11 × RF3 × MON 88302) |
BASF Australia Ltd |
Agricultural | Commercial | Current | ||
Clinical trial of genetically modified human adenovirus for bladder cancer treatment |
Novotech (Australia) Pty Limited |
Medical | Limited and controlled | Current | ||
Limited and controlled release of white clover genetically modified for increased condensed tannins |
Grasslanz Technology Australia Pty Limited |
Agricultural | Limited and controlled | Current | ||
Commercial release of canola (Brassica napus) genetically modified for herbicide tolerance and a hybrid breeding system (MS11) |
BASF Australia Ltd |
Agricultural | Commercial | Current | ||
Commercial supply of a genetically modified cholera vaccine, Vaxchora® |
Biocelect Pty Ltd |
Medical | Commercial | Current | ||
Commercial release of cotton genetically modified for herbicide tolerance (MON 88701) |
Monsanto Australia Pty Ltd |
Agricultural | Commercial | Current | ||
Clinical trial of genetically modified influenza vaccine (H3N2 M2SR) |
Novotech (Australia) Pty Ltd |
Medical | Limited and controlled | Current | ||
Limited and controlled release of microalgae genetically modified for increased production of fatty acids |
The University of Queensland |
Other | Limited and controlled | Current | ||
Limited and controlled release of chickpea genetically modified for drought and other environmental stress tolerance |
Queensland University of Technology |
Agricultural | Limited and controlled | Current | ||
Limited and controlled release of wheat genetically modified for altered iron uptake, transport and bioavailability |
The University of Melbourne |
Agricultural | Limited and controlled | Current | ||
Limited and controlled release of canola genetically modified for herbicide tolerance |
Monsanto Australia Limited |
Agricultural | Limited and controlled | Current | ||
Limited and controlled release of canola genetically modified for altered oil content and herbicide tolerance |
Nuseed Pty Ltd |
Agricultural | Limited and controlled | Current | ||
Limited and controlled release of bread wheat and durum wheat genetically modified for enhanced rust disease resistance |
CSIRO |
Agricultural | Limited and controlled | Current | ||
A genetically modified respiratory syncytial virus (RSV) vaccine for use in clinical trials |
Novotech (Australia) Pty Ltd |
Medical | Limited and controlled | Current | ||
Limited and controlled release of genetically modified insect-specific viruses as vaccines against Kunjin virus infection in farmed crocodiles |
The University of Queensland |
Medical | Limited and controlled | Current | ||
Commercial release of safflower genetically modified for high oleic acid composition |
Go Resources Pty Ltd |
Agricultural | Commercial | Current | ||
Commercial release of cotton genetically modified for insect resistance (COT102) |
Syngenta Australia Pty Ltd |
Agricultural | Commercial | Current | ||
Limited and controlled release of buffalo grass genetically modified for herbicide tolerance and dwarf phenotype |
Royal Melbourne Institute of Technology University |
Agricultural | Limited and controlled | Current | ||
Commercial release of canola genetically modified for omega-3 oil content (DHA canola) |
Nuseed Pty Ltd |
Agricultural | Commercial | Current | ||
Limited and controlled release of a GM vaccine for chickens, Vaxsafe® ILT |
Bioproperties Pty Ltd |
Agricultural | Limited and controlled | Current | ||
Limited and controlled release of sorghum genetically modified for grain quality traits |
University of Queensland |
Agricultural | Limited and controlled | Current | ||
Limited and controlled release of wheat and barley genetically modified for abiotic stress tolerance and yield improvement |
The University of Adelaide |
Agricultural | Limited and controlled | Current | ||
Limited and controlled release of wheat genetically modified for disease resistance, drought tolerance, altered oil content and altered grain composition |
CSIRO |
Agricultural | Limited and controlled | Current | ||
Limited and controlled release of Indian mustard (Juncea canola) genetically modified for altered oil content |
Nuseed Pty Ltd |
Agricultural | Limited and controlled | Current | ||
Commercial supply of Dengvaxia, an attenuated GM dengue vaccine |
Sanofi-Aventis Australia Pty Ltd |
Medical | Commercial | Current | ||
Limited and controlled release of cotton genetically modified for insect resistance and herbicide tolerance |
Monsanto Australia Limited |
Agricultural | Limited and controlled | Current | ||
Limited and controlled release of banana genetically modified for disease resistance |
Queensland University of Technology |
Agricultural | Limited and controlled | Current | ||
Commercial release of cotton genetically modified for insect resistance and herbicide tolerance (Bollgard® 3 XtendFlex™ and XtendFlex™ cotton) |
Monsanto Australia Limited |
Agricultural | Commercial | Current | ||
Clinical trial of live attenuated genetically modified influenza vaccines |
Novotech (Australia) Pty Ltd |
Medical | Limited and controlled | Current | ||
Commercial release of cotton genetically modified for insect resistance and herbicide tolerance (GlyTol® (BCS-GH002-5) and GlyTol TwinLink Plus® (BCS-GH002-5 x BCS-GH004-7 x BCS-GH005-8 x SYN-IR102-7) |
BASF Australia Ltd |
Agricultural | Commercial | Current | ||
Clinical trial of a genetically modified virus for treatment of liver, kidney and prostate cancer |
Novotech (Australia) Pty Ltd |
Medical | Limited and controlled | Current | ||
Commercial release of canola genetically modified for herbicide tolerance |
Pioneer Hi-Bred Australia Pty Ltd |
Agricultural | Commercial | Current | ||
Commercial release of canola genetically modified for dual herbicide tolerance and a hybrid breeding system |
BASF Australia Ltd |
Agricultural | Commercial | Current | ||
Commercial supply of attenuated GM influenza vaccines |
AstraZeneca Pty Ltd |
Medical | Commercial | Current | ||
Commercial supply of a tumour-selective genetically modified virus for cancer therapy |
Amgen Australia Pty Ltd |
Medical | Commercial | Current | ||
Commercial release of canola genetically modified for herbicide tolerance |
Monsanto Australia Ltd |
Agricultural | Commercial | Current | ||
Commercial release of genetically modified vaccine to protect chickens against pathogenic Escherichia coli |
Zoetis Australia Research & Manufacturing Pty Ltd |
Agricultural | Commercial | Current | ||
Commercial release of GM insect resistant and herbicide tolerant (COT102 x MON-15985 Bollgard®III and COT102 x MON-15985 x MON 88913 Bollgard®III x Roundup Ready Flex®) cotton |
Monsanto Australia Ltd |
Agricultural | Commercial | Current | ||
Commercial release of herbicide tolerant (Roundup Ready Flex®MON88913) pima cotton in Australia |
Monsanto Australia Ltd |
Agricultural | Commercial | Current | ||
Commercial release of canola genetically modified for herbicide tolerance and a hybrid breeding system |
BASF Australia Ltd |
Agricultural | Commercial | Current |